Format

Send to

Choose Destination
Curr Infect Dis Rep. 2011 Apr;13(2):196-204. doi: 10.1007/s11908-011-0169-9.

Gonococcal resistance: are cephalosporins next?

Author information

1
Division of STD Prevention, National Center for HIV, Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, 1600 Clifton Road, E-02, Atlanta, GA, 30333, USA, hgl8@cdc.gov.

Abstract

The development of resistance to multiple antibiotics has limited treatment options for gonorrhea in many countries. Currently, the Centers for Disease Control and Prevention only recommend cephalosporin antibiotics for treatment of uncomplicated gonorrhea. Although the cephalosporins remain effective, the demonstrated ability of Neisseria gonorrhoeae to develop resistance has raised concerns about the possibility of multidrug-resistant N. gonorrhoeae strains, which include cephalosporin resistance. This article provides a review of global trends in cephalosporin susceptibility among gonococcal isolates, recent findings that deepen our understanding of genetic mechanisms of resistance, and the public health and clinical implications of the potential emergence of cephalosporin-resistant gonorrhea.

PMID:
21365384
DOI:
10.1007/s11908-011-0169-9

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center